MEIP: Mei Pharma Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Mei Pharma Inc (MEIP).
$19.39M Market Cap.
MEIP Market Cap. (MRY)
MEIP Shares Outstanding (MRY)
MEIP Assets (MRY)
Total Assets
$41.38M
Total Liabilities
$8.36M
Total Investments
$34.64M
MEIP Income (MRY)
Revenue
$65.30M
Net Income
$17.78M
Operating Expense
$50.76M
MEIP Cash Flow (MRY)
CF Operations
-$50.47M
CF Investing
$49.14M
CF Financing
-$11.87M
MEIP Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $41,375,000 (-65.75%) | $120,809,000 (-32.07%) | $177,840,000 (2.15%) | $174,098,000 (-16.99%) |
Assets Current | $40,769,000 (-62.09%) | $107,528,000 (-35.66%) | $167,126,000 (1.40%) | $164,817,000 (-21.01%) |
Assets Non-Current | $606,000 (-95.44%) | $13,281,000 (23.96%) | $10,714,000 (15.44%) | $9,281,000 (756.18%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $33,020,000 (34.10%) | $24,624,000 (-53.02%) | $52,413,000 (5.96%) | $49,466,000 (-35.81%) |
Property Plant & Equipment Net | $606,000 (-95.44%) | $13,281,000 (23.96%) | $10,714,000 (15.44%) | $9,281,000 (756.18%) |
Cash & Equivalents | $3,705,000 (-78.08%) | $16,906,000 (7.41%) | $15,740,000 (-89.74%) | $153,426,000 (-15.99%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $64,862,000 (-32.04%) | $95,444,000 (20.48%) | $79,222,000 (-5.30%) |
Total Investments | $34,640,000 (-58.66%) | $83,787,000 (-39.07%) | $137,512,000 (0%) | $0 (0%) |
Investments Current | $34,640,000 (-58.66%) | $83,787,000 (-39.07%) | $137,512,000 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $85,000 (-99.15%) | $10,044,000 (32.47%) | $7,582,000 (165.29%) |
Trade & Non-Trade Payables | $3,168,000 (-48.35%) | $6,134,000 (-22.53%) | $7,918,000 (24.59%) | $6,355,000 (160.77%) |
Accumulated Retained Earnings (Deficit) | -$388,219,000 (4.38%) | -$405,997,000 (-8.51%) | -$374,159,000 (-17.03%) | -$319,705,000 (-14.84%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $0 (0%) | $12,728,000 (32.01%) | $9,642,000 (16.20%) | $8,298,000 (0%) |
Debt Current | $0 (0%) | $1,428,000 (63.95%) | $871,000 (-6.14%) | $928,000 (0%) |
Debt Non-Current | $0 (0%) | $11,300,000 (28.83%) | $8,771,000 (19.01%) | $7,370,000 (0%) |
Total Liabilities | $8,355,000 (-91.31%) | $96,185,000 (-23.31%) | $125,427,000 (0.64%) | $124,632,000 (-6.06%) |
Liabilities Current | $8,355,000 (-58.92%) | $20,340,000 (-16.79%) | $24,443,000 (20.94%) | $20,211,000 (46.92%) |
Liabilities Non-Current | $0 (0%) | $75,845,000 (-24.89%) | $100,984,000 (-3.29%) | $104,421,000 (-12.19%) |
MEIP Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $65,297,000 (33.76%) | $48,816,000 (19.95%) | $40,697,000 (16.96%) | $34,796,000 (25.36%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $1,408,000 (-47.29%) |
Selling General & Administrative Expense | $23,295,000 (-29.69%) | $33,130,000 (8.48%) | $30,540,000 (25.09%) | $24,414,000 (46.04%) |
Research & Development Expense | $16,561,000 (-68.43%) | $52,450,000 (-38.76%) | $85,641,000 (23.41%) | $69,398,000 (103.72%) |
Operating Expenses | $50,755,000 (-40.69%) | $85,580,000 (-26.34%) | $116,181,000 (23.84%) | $93,812,000 (84.73%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $8,000 (700.00%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | $17,778,000 (155.84%) | -$31,838,000 (41.53%) | -$54,454,000 (-31.81%) | -$41,314,000 (12.42%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | $17,778,000 (155.84%) | -$31,838,000 (41.53%) | -$54,454,000 (-31.81%) | -$41,314,000 (12.42%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | $17,778,000 (155.84%) | -$31,838,000 (41.53%) | -$54,454,000 (-31.81%) | -$41,314,000 (12.42%) |
Weighted Average Shares | $6,663,000 (0.00%) | $6,663,000 (7.05%) | $6,224,000 (10.62%) | $5,626,350 (23.55%) |
Weighted Average Shares Diluted | $6,663,000 (0.00%) | $6,663,000 (6.49%) | $6,257,000 (9.31%) | $5,724,050 (25.69%) |
Earning Before Interest & Taxes (EBIT) | $17,778,000 (155.84%) | -$31,838,000 (41.53%) | -$54,454,000 (-31.83%) | -$41,306,000 (12.44%) |
Gross Profit | $65,297,000 (33.76%) | $48,816,000 (19.95%) | $40,697,000 (21.89%) | $33,388,000 (33.10%) |
Operating Income | $14,542,000 (139.55%) | -$36,764,000 (51.30%) | -$75,484,000 (-24.92%) | -$60,424,000 (-135.14%) |
MEIP Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $49,140,000 (-8.47%) | $53,690,000 (679.02%) | $6,892,000 (-72.11%) | $24,708,000 (123.24%) |
Net Cash Flow from Financing | -$11,868,000 (-29570.00%) | -$40,000 (-100.08%) | $49,051,000 (1314.39%) | $3,468,000 (-95.36%) |
Net Cash Flow from Operations | -$50,473,000 (3.83%) | -$52,484,000 (-7.67%) | -$48,746,000 (-52.50%) | -$31,964,000 (-193.30%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$13,201,000 (-1232.16%) | $1,166,000 (-83.80%) | $7,197,000 (289.99%) | -$3,788,000 (-238.20%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $49,147,000 (-8.52%) | $53,725,000 (628.87%) | $7,371,000 (-71.00%) | $25,416,000 (124.11%) |
Capital Expenditure | -$7,000 (80.00%) | -$35,000 (92.69%) | -$479,000 (32.34%) | -$708,000 (20.81%) |
Issuance (Repayment) of Debt Securities | -$208,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $0 (0%) | $0 (0%) | $52,897,000 (1397.65%) | $3,532,000 (-95.50%) |
Payment of Dividends & Other Cash Distributions | -$11,660,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $2,278,000 (-36.53%) | $3,589,000 (-57.02%) | $8,350,000 (-18.50%) | $10,245,000 (50.64%) |
Depreciation Amortization & Accretion | $2,816,000 (55.15%) | $1,815,000 (46.96%) | $1,235,000 (333.33%) | $285,000 (161.47%) |
MEIP Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% (4.17%) | 96.00% (6.19%) |
Profit Margin | 27.20% (141.72%) | -65.20% (51.27%) | -133.80% (-12.72%) | -118.70% (30.18%) |
EBITDA Margin | 31.50% (151.22%) | -61.50% (52.98%) | -130.80% (-10.94%) | -117.90% (30.48%) |
Return on Average Equity (ROAE) | 31.60% (135.91%) | -88.00% (7.95%) | -95.60% (-44.85%) | -66.00% (3.37%) |
Return on Average Assets (ROAA) | 24.30% (208.00%) | -22.50% (21.60%) | -28.70% (-35.38%) | -21.20% (45.78%) |
Return on Sales (ROS) | 27.20% (141.72%) | -65.20% (51.27%) | -133.80% (-12.72%) | -118.70% (30.18%) |
Return on Invested Capital (ROIC) | 25.50% (127.54%) | -92.60% (21.06%) | -117.30% (88.72%) | -1039.80% (-141.81%) |
Dividend Yield | 60.10% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | 1.09 (179.16%) | -1.38 (0.43%) | -1.38 (82.05%) | -7.7 (3.01%) |
Price to Sales Ratio (P/S) | 0.3 (-66.93%) | 0.9 (-51.49%) | 1.85 (-79.92%) | 9.22 (-31.99%) |
Price to Book Ratio (P/B) | 0.59 (-67.02%) | 1.78 (15.81%) | 1.54 (-76.31%) | 6.49 (14.19%) |
Debt to Equity Ratio (D/E) | 0.25 (-93.52%) | 3.91 (63.23%) | 2.39 (-5.04%) | 2.52 (46.34%) |
Earnings Per Share (EPS) | 2.67 (155.86%) | -4.78 (45.37%) | -8.75 (-18.24%) | -7.4 (28.85%) |
Sales Per Share (SPS) | 9.8 (33.77%) | 7.33 (12.04%) | 6.54 (5.74%) | 6.18 (1.46%) |
Free Cash Flow Per Share (FCFPS) | -7.58 (3.88%) | -7.88 (0.34%) | -7.91 (-36.20%) | -5.81 (-179.27%) |
Book Value Per Share (BVPS) | 4.96 (34.09%) | 3.7 (-56.11%) | 8.42 (-4.22%) | 8.79 (-48.04%) |
Tangible Assets Book Value Per Share (TABVPS) | 6.21 (-65.75%) | 18.13 (-36.54%) | 28.57 (-7.66%) | 30.94 (-32.81%) |
Enterprise Value Over EBIT (EV/EBIT) | 2 (0.00%) | 2 (100.00%) | 1 (125.00%) | -4 (42.86%) |
Enterprise Value Over EBITDA (EV/EBITDA) | 1.39 (-24.17%) | 1.84 (24.63%) | 1.47 (136.69%) | -4.02 (45.20%) |
Asset Turnover | 0.89 (158.84%) | 0.34 (60.47%) | 0.21 (20.11%) | 0.18 (-22.17%) |
Current Ratio | 4.88 (-7.70%) | 5.29 (-22.67%) | 6.84 (-16.16%) | 8.15 (-46.23%) |
Dividends | $1.75 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$50,480,000 (3.88%) | -$52,519,000 (-6.69%) | -$49,225,000 (-50.66%) | -$32,672,000 (-197.93%) |
Enterprise Value (EV) | $28,687,914 (152.03%) | -$55,142,401 (29.71%) | -$78,446,013 (-147.61%) | $164,770,567 (-52.24%) |
Earnings Before Tax (EBT) | $17,778,000 (155.84%) | -$31,838,000 (41.53%) | -$54,454,000 (-31.83%) | -$41,306,000 (12.44%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | $20,594,000 (168.59%) | -$30,023,000 (43.59%) | -$53,219,000 (-29.74%) | -$41,021,000 (12.84%) |
Invested Capital | $29,315,000 (-69.56%) | $96,291,000 (-34.63%) | $147,299,000 (1581.69%) | $8,759,000 (-34.35%) |
Working Capital | $32,414,000 (-62.82%) | $87,188,000 (-38.89%) | $142,683,000 (-1.33%) | $144,606,000 (-25.80%) |
Tangible Asset Value | $41,375,000 (-65.75%) | $120,809,000 (-32.07%) | $177,840,000 (2.15%) | $174,098,000 (-16.99%) |
Market Capitalization | $19,388,914 (-55.78%) | $43,841,599 (-45.58%) | $80,556,987 (-74.90%) | $320,886,567 (-26.70%) |
Average Equity | $56,224,500 (55.47%) | $36,165,000 (-36.51%) | $56,963,500 (-8.95%) | $62,563,500 (-9.37%) |
Average Assets | $73,106,000 (-48.35%) | $141,544,500 (-25.31%) | $189,521,000 (-2.57%) | $194,527,250 (61.31%) |
Invested Capital Average | $69,826,750 (103.16%) | $34,369,750 (-25.98%) | $46,433,500 (1068.87%) | $3,972,500 (309.41%) |
Shares | 6,662,857 (0.00%) | 6,662,857 (0.08%) | 6,657,602 (18.26%) | 5,629,589 (6.22%) |
